Følg
Paul Bieniasz
Paul Bieniasz
Professor, The Rockefeller university
Verifisert e-postadresse på rockefeller.edu
Tittel
Sitert av
Sitert av
År
A diverse range of gene products are effectors of the type I interferon antiviral response
JW Schoggins, SJ Wilson, M Panis, MY Murphy, CT Jones, P Bieniasz, ...
Nature 472 (7344), 481-485, 2011
25222011
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
SJD Neil, T Zang, PD Bieniasz
Nature 451 (7177), 425-430, 2008
23562008
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ...
Nature 584 (7821), 437-442, 2020
19412020
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
MJ Evans, T Von Hahn, DM Tscherne, AJ Syder, M Panis, B Wölk, ...
Nature 446 (7137), 801-805, 2007
16662007
Evolution of antibody immunity to SARS-CoV-2
C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ...
Nature 591 (7851), 639-644, 2021
16302021
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ...
Nature 592 (7855), 616-622, 2021
14382021
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ...
elife 9, e61312, 2020
14342020
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress
J Martin-Serrano, T Zang, PD Bieniasz
Nature medicine 7 (12), 1313-1319, 2001
9202001
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies
CO Barnes, AP West, KE Huey-Tubman, MAG Hoffmann, NG Sharaf, ...
Cell 182 (4), 828-842. e16, 2020
7502020
Tetherin inhibits HIV-1 release by directly tethering virions to cells
D Perez-Caballero, T Zang, A Ebrahimi, MW McNatt, DA Gregory, ...
Cell 139 (3), 499-511, 2009
7372009
Vaccine breakthrough infections with SARS-CoV-2 variants
E Hacisuleyman, C Hale, Y Saito, NE Blachere, M Bergh, EG Conlon, ...
New England Journal of Medicine 384 (23), 2212-2218, 2021
7292021
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Z Wang, F Muecksch, D Schaefer-Babajew, S Finkin, C Viant, C Gaebler, ...
Nature 595 (7867), 426-431, 2021
7052021
HIV restriction factors and mechanisms of evasion
MH Malim, PD Bieniasz
Cold Spring Harbor perspectives in medicine 2 (5), a006940, 2012
6142012
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
F Klein, A Halper-Stromberg, JA Horwitz, H Gruell, JF Scheid, ...
Nature 492 (7427), 118-122, 2012
5742012
Intrinsic immunity: a front-line defense against viral attack
PD Bieniasz
Nature immunology 5 (11), 1109-1115, 2004
5702004
MX2 is an interferon-induced inhibitor of HIV-1 infection
M Kane, SS Yadav, J Bitzegeio, SB Kutluay, T Zang, SJ Wilson, ...
Nature 502 (7472), 563-566, 2013
5662013
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ...
Journal of Experimental Medicine 217 (11), e20201181, 2020
5372020
Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains
D Sauter, M Schindler, A Specht, WN Landford, J Münch, KA Kim, ...
Cell host & microbe 6 (5), 409-421, 2009
5112009
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
GJ Towers, T Hatziioannou, S Cowan, SP Goff, J Luban, PD Bieniasz
Nature medicine 9 (9), 1138-1143, 2003
5002003
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α
T Hatziioannou, D Perez-Caballero, A Yang, S Cowan, PD Bieniasz
Proceedings of the National Academy of Sciences 101 (29), 10774-10779, 2004
4762004
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20